Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Warner

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Psychiatric Research|October 1, 1974
Independence of glucocorticosteroids and blood-brain barrier amino acid permeabilityR B Warner, A R Dick
The American Journal of Psychiatry|August 1, 1979
Problems with internalization of a transplanted liverS L Dubovsky, J L Metzner, R B Warner
Journal of Autonomic Pharmacology|August 1, 1992
Orthostatic hypotension occurs following alpha 2-adrenoceptor blockade in chronic prazosin-pretreated conscious spontaneously hypertensive ratsJ Y Lee, M E Brune, R B Warner, et al.
Pharmacology|November 1, 1994
Endothelin ETA receptor antagonist reduces myocardial infarction induced by coronary artery occlusion and reperfusion in the ratJ Y Lee, R B Warner, A L Adler, et al.
General Pharmacology|January 1, 1990
Calcium-induced vasocontractions after alpha-2 adrenergic receptor activation in the dog saphenous vein: comparison to calcium-induced contractions after potassium-depolarizationJ Y Lee, R B Warner, M E Brune, et al.
Pharmacology|February 19, 1998
Cardiovascular activity of A-74283, a 5-hydroxytryptamine 1A agent, in the spontaneously hypertensive ratJ Y Lee, A A Hancock, R B Warner, et al.
Journal of Receptor Research|May 1, 1994
Receptor interactions of Abbott-81988, a highly potent, non-peptide angiotensin-II antagonist selective for type-1 receptorsA A Hancock, S A Buckner, J Y Lee, et al.
Life Sciences|January 1, 1993
Pharmacological characterization of Abbott-81282, a novel, non-peptide angiotensin-II antagonist selective for type-1 receptorsA A Hancock, S A Buckner, J Y Lee, et al.
American Journal of Hypertension|November 1, 1994
Cardiovascular effects of orally administered ABBOTT-81988, an angiotensin II antagonist, in conscious spontaneously hypertensive ratsJ Y Lee, R B Warner, M E Brune, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Characterization of antihypertensive activity of ABBOTT-81988, a nonpeptide angiotensin II antagonist in the renal hypertensive ratJ Y Lee, S A Buckner, M E Brune, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Psychiatric Research|October 1, 1974
Independence of glucocorticosteroids and blood-brain barrier amino acid permeabilityR B Warner, A R Dick
The American Journal of Psychiatry|August 1, 1979
Problems with internalization of a transplanted liverS L Dubovsky, J L Metzner, R B Warner
Journal of Autonomic Pharmacology|August 1, 1992
Orthostatic hypotension occurs following alpha 2-adrenoceptor blockade in chronic prazosin-pretreated conscious spontaneously hypertensive ratsJ Y Lee, M E Brune, R B Warner, et al.
Pharmacology|November 1, 1994
Endothelin ETA receptor antagonist reduces myocardial infarction induced by coronary artery occlusion and reperfusion in the ratJ Y Lee, R B Warner, A L Adler, et al.
General Pharmacology|January 1, 1990
Calcium-induced vasocontractions after alpha-2 adrenergic receptor activation in the dog saphenous vein: comparison to calcium-induced contractions after potassium-depolarizationJ Y Lee, R B Warner, M E Brune, et al.
Pharmacology|February 19, 1998
Cardiovascular activity of A-74283, a 5-hydroxytryptamine 1A agent, in the spontaneously hypertensive ratJ Y Lee, A A Hancock, R B Warner, et al.
Journal of Receptor Research|May 1, 1994
Receptor interactions of Abbott-81988, a highly potent, non-peptide angiotensin-II antagonist selective for type-1 receptorsA A Hancock, S A Buckner, J Y Lee, et al.
Life Sciences|January 1, 1993
Pharmacological characterization of Abbott-81282, a novel, non-peptide angiotensin-II antagonist selective for type-1 receptorsA A Hancock, S A Buckner, J Y Lee, et al.
American Journal of Hypertension|November 1, 1994
Cardiovascular effects of orally administered ABBOTT-81988, an angiotensin II antagonist, in conscious spontaneously hypertensive ratsJ Y Lee, R B Warner, M E Brune, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Characterization of antihypertensive activity of ABBOTT-81988, a nonpeptide angiotensin II antagonist in the renal hypertensive ratJ Y Lee, S A Buckner, M E Brune, et al.
Pageof 2